NEW YORK, July 19 (GenomeWeb News) - Carl Zeiss Microimaging and Cellomics announced on July 18 their involvement in two National Institutes of Health initiatives geared towards bringing small molecule screening to basic science researchers.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.
According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.
In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.
CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.